These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 9757871)

  • 1. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
    Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
    Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.
    Wise LA; Palmer JR; Harlow BL; Spiegelman D; Stewart EA; Adams-Campbell LL; Rosenberg L
    Am J Epidemiol; 2004 Jan; 159(2):113-23. PubMed ID: 14718211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral contraceptives and uterine fibroids: results from a case-control study.
    Chiaffarino F; Parazzini F; La Vecchia C; Marsico S; Surace M; Ricci E
    Br J Obstet Gynaecol; 1999 Aug; 106(8):857-60. PubMed ID: 10453838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
    Colditz GA
    Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive characteristics and risk of uterine leiomyomata.
    Terry KL; De Vivo I; Hankinson SE; Missmer SA
    Fertil Steril; 2010 Dec; 94(7):2703-7. PubMed ID: 20627243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of hypertension and risk of uterine leiomyomata.
    Boynton-Jarrett R; Rich-Edwards J; Malspeis S; Missmer SA; Wright R
    Am J Epidemiol; 2005 Apr; 161(7):628-38. PubMed ID: 15781952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of uterine leiomyomata with menstrual and reproductive factors in premenopausal women: Korea nurses' health study.
    Song S; Park S; Song BM; Lee JE; Cha C; Park HY
    BMC Womens Health; 2023 Jun; 23(1):305. PubMed ID: 37296433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
    Wise LA; Palmer JR; Stewart EA; Rosenberg L
    Obstet Gynecol; 2005 Mar; 105(3):563-8. PubMed ID: 15738025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary infertility and oral contraceptive steroid use.
    Bagwell MA; Thompson SJ; Addy CL; Coker AL; Baker ER
    Fertil Steril; 1995 Jun; 63(6):1161-6. PubMed ID: 7750582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking.
    Marshall LM; Spiegelman D; Manson JE; Goldman MB; Barbieri RL; Stampfer MJ; Willett WC; Hunter DJ
    Epidemiology; 1998 Sep; 9(5):511-7. PubMed ID: 9730029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
    Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
    Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women.
    Hunter DJ; Manson JE; Colditz GA; Chasan-Taber L; Troy L; Stampfer MJ; Speizer FE; Willett WC
    Contraception; 1997 Dec; 56(6):373-8. PubMed ID: 9494771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
    Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ
    Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?
    Khoo SK
    Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral contraceptives and risk of breast cancer in young women.
    Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
    Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.